GASTRIC INHIBITORY POLYPEPTIDE DIAGNOSTIC TEST FOR DETECTING SUSCEPTIBILITY TO TYPE-2 DIABETES, IMPAIRED GLUCOSE TOLERANCE, OR IMPAIRED FASTING GLUCOS - Patent 1356295

(19)

(11)

EP 1 356 295 A2

(12)

(88)	Date of publication A3:
	24.04.2003

(43)	Date of publication:
	29.10.2003 Bulletin 2003/44

(21)	Application number: 01930773.5

(22)	Date of filing: 26.04.2001

(51)	International Patent Classification (IPC)⁷: G01N 33/68

(86)	International application number:
	PCT/US0113/378

(87)	International publication number:
	WO 0108/1919 (01.11.2001 Gazette 2001/44)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

27.04.2000 US 559779

(71)	Applicant: BIONEBRASKA, INC.
	Lincoln, NB 68524 (US)

(72)	Inventors:
	NAUCK, Michael, A. 37431 Bad Lauterberg im Harz (DE) MEIER, Juris, J. 44852 Bochum (DE) HUECKING, Katrin 58640 Iserlohn (DE)

(74)	Representative: Thomson, Paul Anthony
	Potts, Kerr & Co.,15, Hamilton Square Birkenhead,Merseyside CH41 6BR Birkenhead,Merseyside CH41 6BR (GB)

(54)	GASTRIC INHIBITORY POLYPEPTIDE DIAGNOSTIC TEST FOR DETECTING SUSCEPTIBILITY TO TYPE-2 DIABETES, IMPAIRED GLUCOSE TOLERANCE, OR IMPAIRED FASTING GLUCOS